1. Home
  2. ENOV

as 07-26-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Fluid Controls

Nasdaq

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

Founded: 1995 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 2.6B IPO Year: 2008
Target Price: $71.40 AVG Volume (30 days): 667.2K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.49 EPS Growth: N/A
52 Week Low/High: $43.04 - $65.03 Next Earning Date: 08-07-2024
Revenue: $1,817,312,000 Revenue Growth: 14.02%
Revenue Growth (this year): 26.76% Revenue Growth (next year): 7.39%

ENOV Daily Stock ML Predictions

Share on Social Networks: